Biomea to present preclinical data from multiple in vivo studiesBiomea plans to initiate a Phase I/II clinical trial of BMF-219…
DSMB met to evaluate interim clinical and safety data and clears Phase 2/3 study to continueSAN DIEGO, March 14, 2022…
Vancouver, British Columbia--(Newsfile Corp. - March 14, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the…
St. John's, Newfoundland--(Newsfile Corp. - March 14, 2022) - Environmentally friendly and socially responsible technologies have become important differentiators in…
New AI and automation solutions will transform the customer experience PALO ALTO, Calif. & DALLAS--(BUSINESS WIRE)--#AI--Uniphore, the leader in conversational…
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights…
DALLAS--(BUSINESS WIRE)--#Healthcare--AIM Specialty Health deems LiverMultiScan® medically necessary for evaluating diffuse liver diseases, covering over 77 million US lives. This…
The enhanced program offers multiple partner tiers with additional benefits to supercharge ISV partner growth, business expansion, and accelerated healthcare…
Leading patient engagement platform ushers in next generation of healthcare communication and automation after recent merger with Radix Health FRANKLIN,…
Company to Demonstrate First 2015 Cures Update Certified EHR and Market-Leading Interoperability Solutions ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN),…